Skip to main content

Table 4 Assessment of platelet activity and reactivity in patients and controls

From: Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

  Patient group Control group Test value p-value
Platelet marker CD41 Mean ± SD 93.8 ± 7.2 92.7 ± 12.5 T = 0.5 0.3
Platelet activation (in vivo) Baseline CD62P % Mean ± SD 32.82 ± 13 25.77 ± 10 T = 3.28 0.001*
Baseline CD62P MFI Mean ± SD 103.6 ± 40.6 79.1 ± 35.2 T = 3.5 0.001*
Platelet reactivity (in vitro) ADP induced CD62P% Mean ± SD 72.95 ± 14.8 62.2 ± 11.39 T = 4.4 < 0.0001*
ADP induced CD62P MFI Mean ± SD 248 ± 101 215 ± 75.8 T = 2 0.04*
  1. *In dependent Student’s T-test is significant at level of significance of 95% (p < 0.05). CD cluster of differentiation, ADP adenosine di-phosphate
  2. bold indicates statistically significant relation
  3. italic indicates the type of the test used